AKT1 and neoplasm: The derivative exerts anti-tumor activity through various mechanisms, such as by inhibiting the STAT3 and TGF-β/Smad signaling pathways, inducing PI3K/Akt, and activating the AMPK/Akt/ERK signaling pathway, which includes cell proliferation and the cell cycle, apoptosis, and cell migration [15].